162 related articles for article (PubMed ID: 8887038)
1. Effects of high-dose intraperitoneal aprotinin treatment on complement activation and acute phase response in acute severe pancreatitis.
Berling R; Ohlsson K
J Gastroenterol; 1996 Oct; 31(5):702-9. PubMed ID: 8887038
[TBL] [Abstract][Full Text] [Related]
2. Peritoneal lavage with aprotinin in patients with severe acute pancreatitis. Effects on plasma and peritoneal levels of trypsin and leukocyte proteases and their major inhibitors.
Berling R; Borgström A; Ohlsson K
Int J Pancreatol; 1998 Aug; 24(1):9-17. PubMed ID: 9746884
[TBL] [Abstract][Full Text] [Related]
3. High-dose intraperitoneal aprotinin treatment of acute severe pancreatitis: a double-blind randomized multi-center trial.
Berling R; Genell S; Ohlsson K
J Gastroenterol; 1994 Aug; 29(4):479-85. PubMed ID: 7524945
[TBL] [Abstract][Full Text] [Related]
4. Tissue kallikrein in severe acute pancreatitis in patients treated with high-dose intraperitoneal aprotinin.
Bläckberg M; Berling R; Ohlsson K
Pancreas; 1999 Nov; 19(4):325-34. PubMed ID: 10547191
[TBL] [Abstract][Full Text] [Related]
5. Acute pancreatitis in man. A clinical and biochemical study of pathophysiology and treatment.
Lasson A
Scand J Gastroenterol Suppl; 1984; 99():1-57. PubMed ID: 6205440
[TBL] [Abstract][Full Text] [Related]
6. Intra-peritoneal aprotinin therapy for acute pancreatitis. Preliminary pharmacodynamic studies.
Larvin M; Mayer AD; McMahon MJ; Müller-Esterl W; Fritz H
Biol Chem Hoppe Seyler; 1988 May; 369 Suppl():149-52. PubMed ID: 2462429
[TBL] [Abstract][Full Text] [Related]
7. Beneficial effects of C1 esterase inhibitor in ST-elevation myocardial infarction in patients who underwent surgical reperfusion: a randomised double-blind study.
Fattouch K; Bianco G; Speziale G; Sampognaro R; Lavalle C; Guccione F; Dioguardi P; Ruvolo G
Eur J Cardiothorac Surg; 2007 Aug; 32(2):326-32. PubMed ID: 17576071
[TBL] [Abstract][Full Text] [Related]
8. Gabexate mesilate vs aprotinin in human acute pancreatitis (GA.ME.P.A.). A prospective, randomized, double-blind multicenter study.
Pederzoli P; Cavallini G; Falconi M; Bassi C
Int J Pancreatol; 1993 Oct; 14(2):117-24. PubMed ID: 7506742
[TBL] [Abstract][Full Text] [Related]
9. Interleukin 10 reduces the incidence of pancreatitis after therapeutic endoscopic retrograde cholangiopancreatography.
Devière J; Le Moine O; Van Laethem JL; Eisendrath P; Ghilain A; Severs N; Cohard M
Gastroenterology; 2001 Feb; 120(2):498-505. PubMed ID: 11159890
[TBL] [Abstract][Full Text] [Related]
10. The effect of peritoneal lavage and aprotinin in the treatment of severe acute pancreatitis.
Balldin G; Borgström A; Genell S; Ohlsson K
Res Exp Med (Berl); 1983; 183(3):203-13. PubMed ID: 6196821
[TBL] [Abstract][Full Text] [Related]
11. Predictive value of complement activation fragments C3a and sC5b-9 for development of severe disease in patients with acute pancreatitis.
Gloor B; Stahel PF; Müller CA; Schmidt OI; Büchler MW; Uhl W
Scand J Gastroenterol; 2003 Oct; 38(10):1078-82. PubMed ID: 14621284
[TBL] [Abstract][Full Text] [Related]
12. [Intraperitoneal perfusion with antienzymes in the treatment of acute pancreatitis].
Lojacono L; Pigliucci GM
Chir Patol Sper; 1970 Apr; 18(2):88-99. PubMed ID: 5316771
[No Abstract] [Full Text] [Related]
13. Pretreatment of a matrix metalloproteases inhibitor and aprotinin attenuated the development of acute pancreatitis-induced lung injury in rat model.
Chu KE; Fong Y; Wang D; Chen CF; Yeh DY
Immunobiology; 2018 Jan; 223(1):64-72. PubMed ID: 29030007
[TBL] [Abstract][Full Text] [Related]
14. Aprotinin in severe acute pancreatitis.
Smith M; Kocher HM; Hunt BJ
Int J Clin Pract; 2010 Jan; 64(1):84-92. PubMed ID: 19178597
[TBL] [Abstract][Full Text] [Related]
15. The effect of peritoneal dialysis with and without aprotinin on acute experimental pancreatitis in rats.
Tilquin BM; O'Connor TC; Hancotte-La Haye CM; Gonze DM; Reynaert MS; De Muylder CG; Kestens PJ
Int Surg; 1990; 75(3):174-8. PubMed ID: 1700770
[TBL] [Abstract][Full Text] [Related]
16. A single-centre double-blind trial of Trasylol therapy in primary acute pancreatitis.
Imrie CW; Benjamin IS; Ferguson JC; McKay AJ; Mackenzie I; O'Neill J; Blumgart LH
Br J Surg; 1978 May; 65(5):337-41. PubMed ID: 348250
[No Abstract] [Full Text] [Related]
17. Morbidity of acute pancreatitis: the effect of aprotinin and glucagon.
Gut; 1980 Apr; 21(4):334-9. PubMed ID: 6159256
[TBL] [Abstract][Full Text] [Related]
18. Death from acute pancreatitis. M.R.C. multicentre trial of glucagon and aprotinin.
Lancet; 1977 Sep; 2(8039):632-5. PubMed ID: 71449
[TBL] [Abstract][Full Text] [Related]
19. Aprotinin inhibits the contact, neutrophil, and platelet activation systems during simulated extracorporeal perfusion.
Wachtfogel YT; Kucich U; Hack CE; Gluszko P; Niewiarowski S; Colman RW; Edmunds LH
J Thorac Cardiovasc Surg; 1993 Jul; 106(1):1-9; discussion 9-10. PubMed ID: 7686593
[TBL] [Abstract][Full Text] [Related]
20. [Intraperitoneal administration of trasylol as an attempt at treatment of acute pancreatitis].
Suszczewska-Fischerowa I
Pol Przegl Chir; 1972 Mar; 44(3):483-95. PubMed ID: 4536985
[No Abstract] [Full Text] [Related]
[Next] [New Search]
